BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8432778)

  • 1. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary.
    Yamada S; Sano T; Stefaneanu L; Kovacs K; Aiba T; Sawano S; Shishiba Y
    J Clin Endocrinol Metab; 1993 Feb; 76(2):352-6. PubMed ID: 8432778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.
    Yamada S; Aiba T; Sano T; Kovacs K; Shishiba Y; Sawano S; Takada K
    Neurosurgery; 1993 Jul; 33(1):20-7. PubMed ID: 7689191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological characterization and subtyping of silent somatotroph adenomas.
    Naritaka H; Kameya T; Sato Y; Furuhata S; Otani M; Kawase T
    Pituitary; 1999 May; 1(3-4):233-41. PubMed ID: 11081203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary somatotroph adenoma producing growth hormone (GH)-releasing hormone (GHRH) with an elevated plasma GHRH concentration: a model case for autocrine and paracrine regulation of GH secretion by GHRH.
    Matsuno A; Katakami H; Sanno N; Ogino Y; Osamura RY; Matsukura S; Shimizu N; Nagashima T
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3241-7. PubMed ID: 10487694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparently silent somatotroph adenomas.
    Pagesy P; Li JY; Kujas M; Peillon F; Delalande O; Visot A; Derome P
    Pathol Res Pract; 1991 Dec; 187(8):950-6. PubMed ID: 1792191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.
    Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW
    J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
    Sanno N; Teramoto A; Osamura RY; Genka S; Katakami H; Jin L; Lloyd RV; Kovacs K
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2731-7. PubMed ID: 9253362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.
    Thapar K; Kovacs K; Stefaneanu L; Scheithauer B; Killinger DW; Lioyd RV; Smyth HS; Barr A; Thorner MO; Gaylinn B; Laws ER
    Am J Pathol; 1997 Sep; 151(3):769-84. PubMed ID: 9284826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological analyses of silent pituitary somatotroph adenomas using immunohistochemistry, in situ hybridization and confocal laser scanning microscopic observation.
    Matsuno A; Itoh J; Itoh Y; Osamura RY; Katayama H; Nagashima T
    Pathol Res Pract; 2001; 197(1):13-20. PubMed ID: 11209812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.
    Li J; Stefaneanu L; Kovacs K; Horvath E; Smyth HS
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(3):193-201. PubMed ID: 8493775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Silent' somatotropinoma.
    Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
    Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-releasing hormone expression in pituitary somatotroph adenomas, studied by immunohistochemistry and in situ hybridization using catalyzed signal amplification system.
    Matsuno A; Katakami H; Nagashima T; Teramoto A; Osamura RY; Kirino T
    Hum Pathol; 2000 Jul; 31(7):789-94. PubMed ID: 10923914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
    Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and prolactin gene expression in human densely and sparsely granulated somatotroph adenomas by in situ hybridization with digoxigenin-labeled probes.
    Yamada S; Takahashi M; Hara M; Sano T; Aiba T; Shishiba Y; Suzuki T; Asa SL
    Diagn Mol Pathol; 1994 Mar; 3(1):46-52. PubMed ID: 8162255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.
    Andreeva M; Georgiev T; Bosadjieva E; Karagiosov L; Karagiosov K; Tomova A; Matrosov P; Kirilov G; Diankov L; Christova T
    Exp Clin Endocrinol; 1991; 98(3):223-7. PubMed ID: 1778242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically silent somatotroph adenomas are common.
    Wade AN; Baccon J; Grady MS; Judy KD; O'Rourke DM; Snyder PJ
    Eur J Endocrinol; 2011 Jul; 165(1):39-44. PubMed ID: 21493729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
    Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.